Skip to main content
Clinical Trials/NCT05607264
NCT05607264CompletedNot Applicable

Kinesio Taping Technique Versus Virtual Reality in Rehabilitation of Patients With Chronic Shoulder Impingement Syndrome

Cairo University1 site in 1 country66 target enrollmentStarted: March 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
66
Locations
1
Primary Endpoint
Assessing the change in musculoskeletal disorders of the upper limbs

Study Overview

Brief Summary

Purpose of the Study: to compare between the effect of kinesio taping technique versus virtual reality technique in rehabilitation of patients with chronic shoulder impingement syndrome.

Detailed Description

Rotator cuff disorders are considered to be among the most common causes of shoulder pain and disability encountered in both primary and secondary care, with subacromial impingement syndrome in particular being the most common disorder, resulting in functional loss and disability, of the shoulder.

There is a lack of literature about virtual reality exergaming in subjects with orthopedic problems.

To reduce UL impairment, new therapeutic approaches, such as constraint-induced movement therapy, robotic arm training, and virtual reality therapy (VRT), have been successfully employed over the last decade.

Kinesio taping is the increasingly popular method for preventing and treating sports injuries. The tape helps to maintain the joint position, increases the proprioceptive awareness, and assists in removal of exudates thereby reducing pain and improves the muscle function.

So as there is lag in literature regarding the best type of treatment for patients with chronic impingement syndrome so this study will be conducted to compare between kinesiotaping and virtual reality and to determine the best treatment for patients with chronic Shoulder Impingement Syndrome (SIS).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients will be diagnosed with chronic shoulder impingement syndrome (who had supraspinatus tendinitis stage (II)
  • •Ages 25-40 years
  • •Both sexes will be included.
  • •Patients complaint from limitation in the ROM in abduction flexion and external rotation.
  • •Patient complaint from pain and tendinitis in subacromial area more than 3 in VAS.
  • •All patients complaint from difficulties in joining ADL activities.
  • •All patients will assign written consent form.

Exclusion Criteria

  • •Subjects with the following criteria will be excluded from the study:
  • •Shoulder fracture or instability.
  • •Previous shoulder surgery.
  • •Arthritis of the glenohumeral or acromioclavicular joints.
  • •Cervical radiculopathy
  • •Patients with visual disorders.
  • •Diabetic patients.
  • •Balance and coordination disorders.
  • •Tumor and breast cancer.
  • •Major trauma.

Arms & Interventions

Virtual Reality training

Experimental

patients who received VR training plus conventional treatment for chronic shoulder impingement syndrome.

Intervention: Conventional treatment (Other)

Kinsiotaping

Experimental

patients who received kinesiotaping plus conventional treatment for chronic shoulder impingement syndrome.

Intervention: Kinsiotaping (Other)

Kinsiotaping

Experimental

patients who received kinesiotaping plus conventional treatment for chronic shoulder impingement syndrome.

Intervention: Conventional treatment (Other)

Virtual Reality training

Experimental

patients who received VR training plus conventional treatment for chronic shoulder impingement syndrome.

Intervention: Motion-controlled VR games (Other)

conventional treatment

Active Comparator

patients who received conventional treatment for chronic shoulder impingement syndrome only.

Intervention: Conventional treatment (Other)

Outcomes

Primary Outcomes

Assessing the change in musculoskeletal disorders of the upper limbs

Time Frame: at baseline and after 4 weeks of intervention

Assessment by using Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH). The DASH is a 30-item self-report questionnaire designed to assess musculoskeletal disorders of the upper limbs. Scoring the DASH 30-item disability/symptom section: 1) Item responses range from 1 (e.g. no difficulty, not at all, not limited, none, strongly disagree) to 5 (e.g. unable, extremely, unable, strongly agree). Scoring the optional 2 4-item high performance sections: 1) Add values of each response, then divide by 4, subtract 1 and multiply by 25: \[((sum of values/4) - 1)\*25\]. 2) Optional modules should not be scored if items are missing. Arabic version of DASH questionnaire will be used, Which is reliable and valid to be used for evaluating upper extremity work related injuries.

Assessing the change in muscle activity of Supraspinatus muscle

Time Frame: at baseline and after 4 weeks of intervention

Assessment by using Electromyogram (EMG). It was used to measure muscle activity of Supraspinatus, infraspinatus, anterior and middle deltoid.

Assessing the change in pain intensity

Time Frame: at baseline and after 4 weeks of intervention

Assessment by using visual analouge scale (VAS). It was used to assess the intensity of pain. Operationally a VAS is usually a horizontal line, l00 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.

Assessing the change in shoulder range of motion

Time Frame: at baseline and after 4 weeks of intervention

Assessment by using Electro goniometer. It was used to measure shoulder ROM (flexion, abduction, internal rotation).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hend Ali Mohamed

Principal investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials